Results 251 to 260 of about 11,408,388 (316)

Current Vaccination Principles and Practices in Adult Cancer Patients. [PDF]

J Clin Pract Res
Elik DB, Kıvrak EE, Yıldırım HÇ, Kılıç AU, Taşbakan M.   +4 more
europepmc   +1 more source

Type I interferons modulate autophagy to shape gemcitabine response in pancreatic cancer cells

FEBS Open Bio, EarlyView.
Type I interferons differentially modulate autophagy and the response of pancreatic cancer cells to gemcitabine. IFNα2b stimulates autophagic flux and protects cells from gemcitabine‐induced cell death, contributing to chemoresistance. In contrast, IFNβ1a inhibits autophagosome formation and enhances gemcitabine‐induced cell death, resulting in ...
Lucy E. Bonilla, Martín M. Ledesma, Santiago A. Behr, Matías A. Pibuel, María L. Palanek, Daniel H. Grasso, Maria N. Garcia, Juan Garona, Silvina L. Lompardía, Elida Álvarez, Daniela L. Papademetrio   +10 more
wiley   +1 more source

Construction and verification of a nomogram to predict the probability of venous thromboembolism in lung cancer patients. [PDF]

Front Mol Biosci
Deng R, Wu J, Tang F, Li Y, Zhong Q, Tong Y, Ni T, Zhang Y.   +7 more
europepmc   +1 more source

The impact of effective dose to the immune cells on survival in breast cancer patients. [PDF]

Clin Transl Radiat Oncol
de Boer SA, Spoor DS, Maduro JH, Deseyne PRAJ, Muijs CT, Sijtsema NM, de Vette SPM, van Dijk LV, Schuit E, Langendijk JA, Crijns APG.   +10 more
europepmc   +1 more source

Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich. [PDF]

J Exp Clin Cancer Res
Pennel KAF, Hatthakarnkul P, Wood CS, Lian GY, Al-Badran SSF, Quinn JA, Legrini A, Inthagard J, Alexander PG, van Wyk H, Kurniawan A, Hashmi U, Gillespie MA, Mills M, Ammar A, Hay J, Andersen D, Nixon C, Rebus S, Chang DK, Kelly C, Harkin A, Graham J, Church D, Tomlinson I, Saunders M, Iveson T, Lannagan TRM, Jackstadt R, Maka N, Horgan PG, Roxburgh CSD, Sansom OJ, McMillan DC, Steele CW, Jamieson NB, Park JH, Roseweir AK, Edwards J.   +38 more
europepmc   +1 more source

Preoperative Glucose-to-Albumin Ratio as a Prognostic Marker for Survival in Pancreatic Cancer Patients Undergoing Pancreatectomy. [PDF]

Cancer Med
Feci A, Lavine I, Shah S, Kraft M, Varughese B, Hoffman E, Rana N, Lavu H, Bowne W, Yeo CJ, Nevler A.   +10 more
europepmc   +1 more source